Always prepare a clean injection site according to standard injection protocols before administering your dose
Tirzepatide activates both GLP-1 and GIP receptors
Most importantly, the gluco-centric paradigm considers the non-glycemic diseases associated with T2D, e.g., obesity, dyslipidemia, hypertension, macrovascular disease, microvascular disease and fatty liver as risk factors and/or outcomes and/or comorbidities, rather than primary inherent disease aspects of T2D
Supports Gut & Digestive Health: By protecting and repairing the stomach lining, this peptide helps with ulcers, leaky gut, and inflammatory bowel conditions
Raw peak areas were utilized for subsequent analysis and no data points were excluded
What GLP-1 Agonists Do in Your Body GLP-1 (glucagon-like peptide-1) is a natural hormone your gut releases when you eat, telling your brain you're satisfied and slowing how fast your stomach empties